Navigation Links
Lilly Caps Successful Year with Strong Fourth-Quarter Results
Date:1/29/2008

- Q4 reported results include 22 percent sales growth and EPS of $.78 - Q4 pro forma adjusted results include 16 percent sales growth and EPS of

$.90 - Full-year results highlighted by double-digit growth in both sales and

EPS

INDIANAPOLIS, Jan. 29 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced financial results for the fourth quarter and full year of 2007.

Throughout this release, financial results are presented on both a reported and a pro forma adjusted basis. Reported results were prepared in accordance with generally accepted accounting principles (GAAP) and include all sales and expenses recognized by the company during the period. Pro forma adjusted results exclude items described in the reconciliation tables below and also assume the ICOS acquisition was completed January 1, 2006. The pro forma adjusted results are presented in order to provide additional insights into the underlying trends in the business. Financial guidance is also provided on both a reported and a pro forma adjusted basis.

Fourth-Quarter Highlights - Reported Results

-- Sales increased 22 percent, to $5.190 billion.

-- Products launched this decade -- Alimta(R), Byetta(R), Cialis(R),

Cymbalta(R), Forteo(R), Strattera(R), Symbyax(R), Xigris(R) and

Yentreve(R) -- collectively grew 55 percent, to $1.7 billion, and

accounted for 33 percent of total sales, compared with 26 percent of

total sales in the fourth quarter of 2006.

-- Net income and earnings per share grew to $854.4 million and $.78,

respectively, compared with fourth-quarter 2006 net income of $132.3'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results Announcement
2. Lilly Announces Dividend Increase
3. Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy
4. International Federation-Lilly Agreement Will Allow Significant Increase in MDR-TB Programmes
5. JDRF and Lilly partner to fund research to identify beta cell biomarkers
6. The Lilly MDR-TB Partnership Provides Unique Model for Fight Against Multidrug-Resistant Tuberculosis in South Africa
7. Lilly Contributes $10.8 Million to United Way Annual Campaign
8. Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
9. Lilly Sets Date and Time for American Heart Association Conference Call
10. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
11. Eli Lilly and Company Aids California Recovery Effort
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Akeso Biomedical, Inc. , a privately ... bacterial infections, microbial biofilms, and chronic wounds, announced that ... directors. , Dr. Sinskey is a ... Institute of Technology, or MIT. He has been a ... also holds positions as Co-Director of the Malaysia-MIT Biotechnology ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... undergoing in vitro fertilization (IVF) are only about half as ... assisted reproduction technique, new research indicates, and the racial disparity ... study, about 31 percent of white patients became pregnant after ... Analyzing more than 4,000 IVF cycles over two years to ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, ... may lead to increased blood pressure, according to a new ... in blood pressure for young adult women or for teenagers, ... drank lightly or moderately, their risk of high blood pressure ... parallels studies in older adult men and women," said lead ...
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... was diagnosed with Ebola while working for NBC News ... leave the special isolation unit at Nebraska Medical Center in Omaha, ... hospital said Tuesday. A blood test confirmed by the U.S. ... can head home to Providence, R.I., NBC News reported ...
Breaking Medicine News(10 mins):Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3
... will have the condition, experts say , , FRIDAY, Jan. 4 (HealthDay ... disability in the United States and now affects 46 million Americans, ... major new report finds. , That number is expected to rise ... percent of American adults will suffer from some form of arthritic ...
... for 29 categories of awards in the 2007 Association ... Best Monthly Professional Society Magazine as well as the ... winners will be honored at the Salute to Association ... 1996, JBS is the official publication of the Society ...
... 4 Align Technology,Inc. (Nasdaq: ALGN ), ... teeth without wires and brackets, announced today that ... end financial results on,Tuesday, January 29, 2008, after ... over PR Newswire and First Call and will ...
... CryoCor, Inc. (Nasdaq:,CRYO), a medical device company ... the publication of a European study of atrial,fibrillation ... of the study was to evaluate the role ... and the effectiveness of an ablation,strategy focused on ...
... El SEGUNDO, Calif., Jan. 4 DaVita Inc. ... Institute, PLC (,SKI,),have formed a wide-ranging partnership to ... chronic kidney disease education and research,in the greater ... SKI,s,existing dialysis centers and programs designed to provide ...
... COLUMBUS, Ohio, Jan. 2 Roxane Laboratories, ... New Drug Application (ANDA),for Granisetron Hydrochloride Tablets, ... The product is available in Unit Dose ... wholesalers and pharmacies nationwide., (Logo: ...
Cached Medicine News:Health News:46 Million Americans Suffer From Arthritis 2Health News:46 Million Americans Suffer From Arthritis 3Health News:Align Technology to Announce Fourth Quarter and 2007 Year End Financial Results on January 29, 2008 2Health News:Align Technology to Announce Fourth Quarter and 2007 Year End Financial Results on January 29, 2008 3Health News:CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation 2Health News:CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation 3Health News:Roxane Laboratories, Inc. Announces the Launch of Granisetron Hydrochloride Tablets, 1mg 2
(Date:10/22/2014)... Inc. (NYSE: CRY ), a leading medical ... vascular surgery, announced today that James Patrick (Pat) ... elected to the Company,s Board of Directors, effective October ... Executive Chairman of CryoLife, stated, "Since joining the Company in ... who is well positioned to maximize CryoLife,s potential.  His ...
(Date:10/22/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... focused on the development of oral drug delivery ... its Phase IIa clinical trial of ORMD-0801, the ... 1 diabetes. The trial was conducted in ... Food and Drug Administration (FDA) Investigational New Drug ...
(Date:10/22/2014)... , Oct. 21, 2014  Early symptoms of ... or unnoticed, but new technology, coupled with yearly, ... leading to earlier detection of eye diseases, including ... million Americans. If left untreated, these diseases can ... Recently, optometric researchers have deployed ...
Breaking Medicine Technology:Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3
Epilation forceps straight ends size 3.5"....
Forceps, extra delicate, straight....
Jewelers Forceps, delicate, straight....
Jewelers Forceps, standard, straight....
Medicine Products: